<DOC>
	<DOCNO>NCT00309335</DOCNO>
	<brief_summary>This Phase 3 clinical study design multicenter , randomize , blind , control study evaluate efficacy , pharmacodynamics , safety NV-101 administer submucosal injection follow completion restorative periodontal maintenance procedure require local anesthesia agent contain vasoconstrictor . Local vasodilatation result rapid clearance anesthetic propose mechanism action .</brief_summary>
	<brief_title>Study NV-101 Efficacy , Pharmacodynamics , Safety Dental Patients Undergoing Maxillary Procedures</brief_title>
	<detailed_description />
	<mesh_term>Phentolamine</mesh_term>
	<criteria>Male female great equal 12 year Sufficiently healthy , determined Investigator , receive routine dental care Requires restorative procedure maxilla cavity preparation , restoration/filling , crown periodontal maintenance procedure , teeth cleaning ( nonsurgical scaling and/or root plan ) side upper mouth Requires one two cartridge local anesthesia administer one follow intraoral injection technique : inferior alveolar nerve block ; GowGates nerve block ; VaziraniAkinosi block ; mentalincisive block ; supraperiosteal injection . Dental procedure complete within 60 minute first administration local anesthetic Normal upper lip sensation baseline prior administration local anesthetic Upper lip side procedure numb ( feel ) completion dental procedure Soft tissue anesthesia recovery score zero prior anesthetic Functional Assessment Battery subject observer rating normal prior anesthetic Negative urine pregnancy test screening female childbearing potential past menarche ( include female except whose menstrual period occur great equal 1 year menopause , surgically sterilize , hysterectomy ) Understands give write informed consent Subjects 12 17 year age give write assent parent ( ) legal guardian ( ) give write informed consent Can communicate Investigator study staff , understand comply requirement protocol History presence condition contraindicate routine dental care Requires two cartridge local anesthetic ( exclude supplemental injection ) use nitrous oxide sedative perform schedule dental procedure Scheduled dental procedure take great 60 minute complete Unable tolerate 1 liter water 5 hour Concurrent condition : incapacitate medical condition ( e.g . unstable angina , uncontrolled cardiac arrhythmia , uncontrolled hypertension , uncontrolled hyperthyroidism ) ; significant infection inflammatory process oral cavity . Concomitant medication : use opioid opioidlike analgesic ( e.g . codeine , tramadol , pentazocine ) within 24 hour prior administration anesthetic Allergy intolerance lidocaine , articaine , prilocaine , mepivacaine , epinephrine , levonordefrin , sulfites , phentolamine , topical benzocaine Has use investigational drug and/or participate clinical study within 30 day study drug administration Has participate study previous study phentolamine mesylate reversal local soft tissue anesthesia ( STA ) Any condition , opinion Investigator , increase risk subject participate study decrease likelihood compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Soft Tissue Anesthesia ( Numbness )</keyword>
</DOC>